About Biogen Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, two co-developed treatments to address a defining pathology of Alzheimers disease, the first treatment to target a genetic form of ALS, the first oral treatment approved for postpartum depression, and the first approved treatment for Friedreichs ataxia
FePt@MnO-based nanotheranostic platform with acidity-triggered dual-ions release for enhanced MR imaging-guided ferroptosis chemodynamic therapy
The Drip Lounge offers confidential, same-day telehealth appointments so you can get expert care, prescriptions, and personalized wellness guidance without leaving home
Mouse pulmonary microthrombi formation assay Male mice were intravenously injected with saline mucin (0.5 mg/kg), FA-PT-A1 (5 mg/kg) or T17-C6-F7 (5 mg/kg)
Patients are often advised to avoid salt substitutes containing potassium chloride , as these can significantly elevate potassium levels